Molecular Characterization and Genotypic Distribution of Hepatitis B Virus Isolates in Iraq: Prevalence of Drug Resistance Mutations
Baghdad Science Journal·
- DOI
- 10.21123/2411-7986.5379
- PMID
- —
- PMCID
- —
- OpenAlex
- W7203631190
- Study type
- Journal article
- Publisher
- College of Science for Women, University of Baghdad
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The findings highlight substantial antiviral resistance among circulating HBV strains in Iraq and underscore the need for continuous surveillance to guide treatment strategies. This is reported as the first local study correlating genotypic variation with drug resistance in this setting.
Structured evidence summary
Research question
The study investigated the distribution of hepatitis B virus genotypes among Iraqi patients and characterized their molecular profiles, including antiviral resistance mutations.
Study design
Molecular characterization study using a modified sequencing protocol to improve success rates in samples with low amplification yields. Subgenotypic analysis and antiviral resistance profiling were performed on HBV isolates.
Population and setting
The study examined HBV isolates from patients in Iraq. The cohort included 68 isolates analyzed for genotypic distribution and drug resistance.
Main findings
HBV genotype D was found in all isolates, with subgenotype D1 accounting for 68% and D3 for 32% of cases. Among HBV/D1 isolates, 47% exhibited antiviral resistance mutations: all resistant isolates showed Lamivudine resistance, 81% had intermediate Entecavir resistance, 19% had high-level Entecavir resistance, and 25% had Telbivudine resistance.
Public-health relevance
The findings highlight substantial antiviral resistance among circulating HBV strains in Iraq and underscore the need for continuous surveillance to guide treatment strategies. This is reported as the first local study correlating genotypic variation with drug resistance in this setting.
Important limitations
This summary relies on the supplied single-article abstract and metadata. The abstract does not explicitly state study limitations such as sample size adequacy, representativeness of the cohort, or clinical outcome data. The original paper is required for decision-grade interpretation.
GIDS interpretation
The article was classified under Hepatitis B and Hepatitis D diseases, Iraq country context, and Surveillance and Treatment topics. These links provide discoverability context for editorial systems but do not indicate connection to a live public health signal.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 9 auditable classifier relationships to diseases, places, topics, and study design.